Company Overview and News

DRDGOLD Limited 2017 Q2 - Results - Earnings Call Slides

2018-02-16 seekingalpha
The following slide deck was published by DRDGOLD Limited in conjunction with their 2017 Q2 earnings call.
Upvote Downvote

Mining Companies Are Suddenly Positive on South Africa Again - Bloomberg

2018-02-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Wired News - DRDGOLD Increases Assets in South Africa With Acquisition of Sibanye-Stillwater's WRTRP Assets in Exchange of 38% Stake

2017-11-28 accesswire
LONDON, UK / ACCESSWIRE / November 28, 2017 / Active-Investors issued a free report on DRDGOLD Ltd. (NYSE: DRD), which is readily accessible upon registration at as the Company's latest news hit the wire. On November 22, 2017, the Company announced that it has entered into an agreement with Sibanye Gold Limited (NYSE: SBGL), trading as Sibanye-Stillwater, to acquire its West Rand Tailings Retreatment Project (WRTRP) assets.
Upvote Downvote

Gold Climbs as North Korea Concerns Increase

2017-08-11 investorplace
Gold stock prices and shares of mining companies jumped on Wednesday amid heightened turmoil surrounding the U.S. and North Korea.
Upvote Downvote

Gold Climbs As North Korea Concerns Increase

2017-08-09 zacks
Gold prices and shares of mining companies jumped on Wednesday amid heightened turmoil surrounding the U.S. and North Korea.
Upvote Downvote

Gold Mining Stocks & ETFs Fall Amid New EU Optimism, Weak Earnings

2017-04-25 zacks
Gold mining stocks and ETFs declined almost universally on Tuesday. Some companies have seen major drops based on recently-reported earnings, but overall, the gold sector is down as a whole amid new European Union optimism.
Upvote Downvote

Technical Roundup on Gold Stocks -- Randgold Resources, Royal Gold, Vista Gold, and DRDGOLD

2017-03-17 prnewswire takes a closer look at some Gold stocks to see how they have fared at the previous close. Up for review are Randgold Resources Ltd (NASDAQ: GOLD), Royal Gold Inc. (NASDAQ: RGLD), Vista Gold Corp. (NYSE MKT: VGZ), and DRDGOLD Ltd (NYSE: DRD). These companies engage in the exploration and production of gold from mines. Many times, they also explore for other metals such as silver, copper, and zinc.
Upvote Downvote

Abandoned S. Africa Mine a ‘Catastrophe,’ Rights Group Say - Bloomberg

2017-01-27 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Why is Gold Down 1.79% Today?

2016-11-07 zacks
On Monday, gold prices are falling, down around 1.79% to $1,285.20, as of 11:03 AM EST, as the financial effects of the FBI’s decision on Sunday to stand by its earlier conclusion that no criminal charges should be brought against Democratic presidential candidate Hillary Clinton carry over into the week.
Upvote Downvote

DRDGOLD's (DRD) CEO Niël Pretorius on Q4 2015 Results - Earnings Call Transcript

2016-09-20 seekingalpha
Good morning, everybody. Thank you very much for attending our results presentation. From myself, Riaan and Jaco, the rest of the management team, we’re pleased to have you here and share with you these results. Riaan and I will take you through the presentation. And then myself, Riaan and Jaco will answer your questions afterwards, after we’ve gone through the prepared presentation.
Upvote Downvote

VSA Capital's Paul Renken: Gold And Lithium Companies That Are Sizzling Hot

2016-09-17 seekingalpha
Currently gold is one of the more interesting commodities: we think that neither the upside nor downside risk is too large.
Upvote Downvote

July Basic Materials: Coal Tops By Yield But Cellulose, Carbon, Copper, And Chemicals Are Best By Brokers

2016-07-27 seekingalpha
Annual yields of ten Basic Materials leaders averaged 9.74% as equities charged bullishly after June as Dow dogs did too.
Upvote Downvote

SunCoke Energy Made Top Basic Materials Yields

2016-06-26 seekingalpha
Annual yields of ten Basic Materials leaders averaged 10.64% but retreated bearishly after May while Dow dogs charged.
Upvote Downvote

Click a Company for JSE:DRD - DRDGOLD Ltd. - Moneyweb

Nature of business DRDGOLD Ltd. (DRDGOLD), which was incorporated on 16 February 1895, owns assets that are primarily involved in the retreatment of surface gold. Based in South Africa, the company does not have a major or controlling shareholder and its directors provide strategic direction on behalf of its shareholders. DRDGOLD is a public company with its primary listing on the JSE Ltd. (JSE), and its secondary listing on the New York Stock Exchange Ltd.
Upvote Downvote

NYU Graduates Seeking $11 Billion of Gold in Ransacked Mine - Bloomberg

2016-04-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...